下載

D-U-N-S® Certified Profile

Issued Date: 2024/05/23
Validity Date: 2027/05/22
Business Basic Informationcheckbox imgVerified by D&B
D-U-N-S® Number 65-673-5425
Business Registration No. 24276040
Company Name GREENRAYS INTERNATIONAL CO., LTD.
Company Type a private company limited by shares
Company Operating Address No. 8, Xingye Rd., Jiatai Industrial Park, Taibao City, Chiayi County, Taiwan
Phone
+886-5-2381832
Fax
+886-5-2381206
Email Contact Us
Company Website www.greenrays.com.tw
Taiwantrade Website of Company greenrays.en.taiwantrade.com/
Line of Business
Retail Sale of Other Food, Beverages and Tobacco in Specialized Stores
Wholesale of Other Food
Retailer of miscellaneous food stores
Main Products
Collagen essence drink
Bitter Melon & Cinnamon EX
Free Form Lutein+GAC
Cranberry Probiotics for Women
Q10-Natto Plus Red Yeast Rice
4X Conc. Antrodia cinnamomea capsule
ZincYes Oral Lonzenges for Immunity Boost
Antrodia cinnamomea Drink
Green Diamond Nuts Snack
Salicylic Acid & Pine Tar Shower Gel
Brand Name
VISLIFE
SIC Code
54990000, 54990102
Employee Here 10~19
Employee Total 10~19
About Companycheckbox imgProvided by Customer


Business Registration Informationcheckbox imgVerified by D&B
Registration Date 2008/12/08
Authorized Capital TWD 150,000,000
Paid Up Capital TWD 75,000,000
Registration Address 2F, No. 8, Xingye Rd., Jiatai Industrial Park, Taibao City, Chiayi County
Name of Representative Xiao, Zhong Bin
Registraction Authority
Management Informationcheckbox imgVerified by D&B
Name Jobtitle On board date
Xiao, Zhong Bin Management Executive
Trading Capabilitycheckbox imgVerified by D&B
No. of Foreign Trading Staff
Bureau of Foreign Trade Information
Import Qualification YES
Export Qualification YES
Actual Import/ Export Value Range
Year Range Import Volumn (USD) Export Volumn (USD)
2024 0 0
2023 0 0
2022 0 0
2021 0 0
2020 0 0
2019 0 0~500,000
2018 0 0~500,000
2017 0 0~500,000
2016 0 0~500,000
2015 0 0~500,000
R&D Capability and Production Capabilitycheckbox imgProvided by Customer
No. of R&D staff 3
R&D Expense to Revenue Ratio in the Most Recent Years 30.00%